Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Study on Single Administration and Dose Increment of Recombinant Human Serum Albumin/Erythrocyte Fusion Protein for Injection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03786289
Recruitment Status : Recruiting
First Posted : December 26, 2018
Last Update Posted : September 13, 2019
Information provided by (Responsible Party):
Tianjin SinoBiotech Ltd.

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Actual Primary Completion Date : July 3, 2019
Estimated Study Completion Date : October 31, 2019